Diabetes Technology Research Group

Diabetes Technology Research Group Our Vision: To improve the lives of people with diabetes through exceptional research, clinical trials and technologies

The Diabetes Technology Research Group (DTRG) is committed to improve the lives of people with diabetes through exceptional research, clinical trials and state-of-the art technologies. Our research is of paramount importance to people with diabetes across a range of areas, including exercise, diet and the development of advanced innovative technologies. We are dedicated to empower our clinical trial participants by providing expert medical advice to help achieve their health goals and thus relieve the impact and burden of diabetes. Our mission would not be possible without the multidisciplinary and complementary expertise of our dedicated team, led by our director Prof David O’Neal who has over 20 years of experience in this field. Our teams’ overarching objective to understand diabetes through research has already transformed thousands of lives each year. We have a strong network of collaborations (over 40 in total) that include local, national, international and patient representative partners, with whom we have generated many publications and clinical guidelines that have been translated into clinical application of the technologies we have investigated. DTRG is a non-profit organisation operating in Victoria, Australia. We are part of the University of Melbourne, Department of Medicine at the St Vincent’s Hospital Campus We provide equal employment opportunities to all persons and promote workplace diversity. Furthermore, DTRG supports and encourages early career scientists in type 1 diabetes research.

We need you to test the new NMX7-AID system to see how the device performs during different types of exercise.To join th...
18/12/2025

We need you to test the new NMX7-AID system to see how the device performs during different types of exercise.

To join this research study, you must:
Be aged at least 18 years of age
Diagnosed with T1D for at least 1 year
Have used the Medtronic MiniMed™ 780G insulin pump for at least 3 months to manage your T1D.

To read more and register your interest, head to our website via this link -> https://www.diabetestechnologyresearchgroup.com.au/the-nmx7-aid-exercise-study/

D.T.R.G would like to wish everyone a safe and happy holidays over the Christmas and new year period. We will be back in...
17/12/2025

D.T.R.G would like to wish everyone a safe and happy holidays over the Christmas and new year period. We will be back in 2026 to deliver more cutting edge research and technology to our participants and community!

It was wonderful to have TrialScreen with us on Friday to talk all things diabetes, research, and automated insulin deli...
08/12/2025

It was wonderful to have TrialScreen with us on Friday to talk all things diabetes, research, and automated insulin delivery! Thank you for helping us highlight the work we do with the Australian diabetes community and the opportunities available through clinical trials.

Type 1 diabetes in your family or community?

This Friday we’re hosting a ResearchFriends conversation with the St Vincent’s team behind world-leading diabetes technology research.

Everyone’s welcome (it's free). Link in comments.

14/11/2025

This , we'd like to highlight this wonderful video of our study nurse and coordinator Jenna, who lives with Type 1 Diabetes. A number of our team members, including Jenna, have lived experience of managing diabetes in the workplace. Their dedication to advocacy and improving clinical outcomes for those living with diabetes are exceptional assets for our team, helping us to offer the best clinical care to our participants.

Today is  .As part of the World Diabetes Day focus on diabetes and well-being, this year the International Diabetes Fede...
13/11/2025

Today is .
As part of the World Diabetes Day focus on diabetes and well-being, this year the International Diabetes Federation is calling for more inclusive and supportive workplaces where people with diabetes feel supported. By strengthening awareness and understanding, we can ensure workplaces where people living with diabetes feel safe, valued, and empowered to thrive.

Important Notice for Potential Research Participants!We appreciate your overwhelming interest in our research projects o...
30/10/2025

Important Notice for Potential Research Participants!
We appreciate your overwhelming interest in our research projects over the past few weeks!
Unfortunately, our "get in touch" form on our website experienced a malfunction, and submissions made before Tuesday 28th October were not received.
If you have recently made an enquiry, please resubmit your details so we can contact you!

https://www.diabetestechnologyresearchgroup.com.au/get-involved/

Thank you!

Get Involved with the D.T.R.G Diabetes clinical trials are an essential part of the development of new interventions

Great news! D.T.R.G have been awarded a prestigious NIH Award, which will fund a new project investigating the use of SG...
24/10/2025

Great news! D.T.R.G have been awarded a prestigious NIH Award, which will fund a new project investigating the use of SGLT inhibitors in people with type 1 diabetes! This project will be lead by Professor David O'Neal, Dr Dale Morrison, and Dr Audrey Kong (pictured left to right).

SGLT inhibitors have transformed the management of type 2 diabetes, saving countless lives by improving glycaemic control and significantly reducing cardiovascular and renal complications. However, their use in T1D has been limited due to the increased risk of diabetic ketoacidosis (DKA) when taking SGLT inhibitors, which can be life threatening.

This study will evaluate whether continuous glucose and ketone monitoring, combined with a tailored response algorithm, can help detect rising ketone levels early and prevent DKA, while allowing people with T1D to experience the many benefits SGLT inhibitors offer.

We are very excited to be bringing this study to Australians living with T1D, and we look forward to sharing the results of this important project in the future!

Last week, D.T.R.G attended  , represented by Dr David O'Neal, Dr Jean Lu, and Dr Jennifer Ngan. Pictured here is Dr Jen...
23/09/2025

Last week, D.T.R.G attended , represented by Dr David O'Neal, Dr Jean Lu, and Dr Jennifer Ngan. Pictured here is Dr Jennifer Ngan giving her presentation on the preliminary results of our PARTNER study, which involves the investigation of free-living ketone profiles collected by continuous ketone monitors in people with type 1 diabetes. To learn more about the findings of this investigation and for access to the publication, follow this link to our website - https://www.diabetestechnologyresearchgroup.com.au/dr-jennifer-ngan-presents-at-easd-2025/

This important trial is currently recruiting participants. To check your eligibility, follow the link to the Diabetes Vi...
16/09/2025

This important trial is currently recruiting participants. To check your eligibility, follow the link to the Diabetes Victoria website:
https://www.diabetesvic.org.au/news-research/take-part-in-research-trials/research-trials-type-1-diabetes/mt-101-101-trial-for-type-1-diabetes/

The MT-101-101 study is a phase 1 clinical trial, testing the safety and dosing of a new treatment for autoimmune diseases including type 1 diabetes. They are looking for people:
🔵 Aged between 18 and 45 years
🔵 Diagnosed with type 1 diabetes
🔵 Residual C-peptide (a measure of insulin production
🔵 Currently using insulin (via injections or by pump)
🔵 Living in Victoria or NSW

If you match this criteria and are interested in being involved, click through and find out more >>> https://bit.ly/4poFcCe

D.T.R.G are currently recruiting participants for a survey for adults with type 1 diabetes exploring nutrition, physical...
07/09/2025

D.T.R.G are currently recruiting participants for a survey for adults with type 1 diabetes exploring nutrition, physical activity and dietary supplement use. Any adult with T1D in Australia is eligible. To complete the survey, scan the QR code in the flyer or follow the link below:
https://q.surveys.unimelb.edu.au/jfe/form/SV_57w0qJJH3Q5DstU

Address

St Vincent’s Hospital
Fitzroy, VIC
3065

Alerts

Be the first to know and let us send you an email when Diabetes Technology Research Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Diabetes Technology Research Group:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram